Sulpho-glucosan derivative and preparation method and application thereof
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN INSTITUTE OF PHARMA RESEARCH
- Publication Date
- 2009-06-03
- Estimated Expiration
- Not applicable · inactive patent
Smart Images
Figure 1 Figure 2 Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of medicine related to diabetes. Specifically, the present invention relates to a sodium glucose transporter type 2 (SGLT2) inhibitor containing a glucosinolate structure, which has a therapeutic effect on diabetes, a preparation method thereof, and a pharmaceutical composition containing them. Background technique
[0002] There are currently about 170 million diabetics in the world, and the vast majority of them are type II (ie, non-insulin-dependent) diabetics. The antidiabetic drugs currently in clinical use mainly include metformin, sulfonylureas and insulin drugs. In recent years, thiazolidinedione drugs, α-glucosidase inhibitors and dipeptidyl peptidase-IV have also been listed on the market. Inhibitors etc. These drugs have good therapeutic effects, but there are safety problems in long-term treatment, such as liver toxicity and weight gain.
[0003] Sodium glucose transporter type 2 (SGLT2) is a new target...